A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ERA OF DIRECT-ACTING ANTIVIRALS?

BACKGROUND: Potent direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection have reduced the need for on-treatment monitoring. Currently, on-treatment response and outcome are determined by HCV RNA testing. A less expensive alternative to verify viral replication is...

詳細記述

保存先:
書誌詳細
出版年:J Can Assoc Gastroenterol
主要な著者: Almarzooqi, S, van Tilborg, M, Maan, R, Vermehren, J, Maasoumy, B, Mazzulli, T, Duarte-Rojo, A, Kowgier, M, Janssen, H L, de Knegt, R, Pawlotsky, J, Cloherty, G, Sarrazin, C, Wedemeyer, H, Feld, J
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Poster Presentations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507833/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.176
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料